8 October 2012
The Care Quality Commission is to carry out an urgent inspection into breast cancer screening, pathology and clinical governance at Sherwood Forest Hospitals NHS Foundation Trust. The inspection will begin today (Monday 8 October).
The announcement comes as the trust announces that it is to recall 79 women with regard to test results relating to breast tissue biopsies.
Monitor has also today announced that it is taking regulatory action to ensure that the Trust has strong leadership, is delivering high quality services for local patients and is financially viable. The Trust was found in significant breach of its terms of authorisation on 21 September.
CQC’s inspection team will include experts in breast screening, pathology and clinical governance. David Haslam, CQC’s national clinical advisor, will provide clinical leadership and support to the team.
CQC has also agreed to carry out a “deep dive” review to reassure Monitor about standards of patient care elsewhere at the Trust.
CQC Chief Executive David Behan said: “This urgent inspection will allow us to take an in-depth look at the quality and safety of the trust’s services that relate to breast cancer screening, pathology and clinical governance. The action we are taking, alongside Monitor’s intervention, will ensure that both regulators have a good picture of the quality and safety of the trust’s services and the robustness of its governance.”
Ends
For media enquiries call the CQC press office on 0207 448 9401 during office hours or out of hours on 07917 232 143.
For general enquiries call 03000 616161.
Find out more
You can see the results of our checks on standards at Sherwood Forest Hospitals NHS Foundation Trust.